Papazisis, G.; Topalidou, X.; Gioula, G.; González, P.A.; Bueno, S.M.; Kalergis, A.M.
Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age. Vaccines 2024, 12, 353.
https://doi.org/10.3390/vaccines12040353
AMA Style
Papazisis G, Topalidou X, Gioula G, González PA, Bueno SM, Kalergis AM.
Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age. Vaccines. 2024; 12(4):353.
https://doi.org/10.3390/vaccines12040353
Chicago/Turabian Style
Papazisis, Georgios, Xanthippi Topalidou, Georgia Gioula, Pablo A. González, Susan M. Bueno, and Alexis M. Kalergis.
2024. "Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age" Vaccines 12, no. 4: 353.
https://doi.org/10.3390/vaccines12040353
APA Style
Papazisis, G., Topalidou, X., Gioula, G., González, P. A., Bueno, S. M., & Kalergis, A. M.
(2024). Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age. Vaccines, 12(4), 353.
https://doi.org/10.3390/vaccines12040353
